🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with numerous of members share comparison photos, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users administering products of unknown origin.

Some experts said the popularity for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Service Response and Material Removal

According to TikTok, the platform has removed problematic material and prohibited associated hashtags and search suggestions. The company stated it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.

Digital Trading Operations

Research also found communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, glowing reviews and step-by-step guides for mixing or administering at residence.

Within moments of entering one group, a seller shared contact information, where most transactions take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Information and Costs

Within these communities, posts display dark colored parcels with postal service labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service stated it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered individuals injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to possibly significant health risks”.